Eilean Therapeutics | ApexOnco - Clinical Trials news and analysis

“OncologyPipeline is my favorite CI tool”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Data insights

29 January 2025

Meanwhile, Olema’s KAT6 inhibitor will take on rival projects from Pfizer and Menarini.

Deals

30 July 2024

Recent Quick take